Strongest earthquake to impact Venezuela since 1900 causes widespread damage across northern Venezuela and highlights challenges within the country’s insurance market BOSTON, July 02, 2026 (GLOBE NEWSWIRE) — The Catastrophe and Risk Solutions group at Verisk (Nasdaq: VRSK), a leading strategic data analytics and technology partner to the global insurance industry, estimates economic losses from the June 24, 2026 earthquakes in Venezuela will likely exceed USD 10 billion. Verisk notes a higher degree of uncertainty than usual in estimating the insured share of industry losses because of Venezuela’s macroeconomic conditions, elevated inflation, low insurance penetration, and sanctions-related market complexities. Earthquake Sequence and Impacts On June 24, Venezuela was struck by a rare earthquake doublet near Yumare-Morón...

SYDNEY, July 02, 2026 (GLOBE NEWSWIRE) — Stellar Resources Limited (ASX: SRZ) is pleased to announce a significant update to the Mineral Resource Estimate (MRE) at its flagship Heemskirk Tin Project in the tier-1 mining jurisdiction of Western Tasmania. The updated MRE features a 64% increase in the Total Mineral Resource at the Severn deposit, reaching 8.54Mt at 0.82% Sn for 70,002 tonnes of contained tin. This pivotal upgrade brings the total Heemskirk Tin Project Resource to 13.36Mt at 0.86% Sn, representing 115.3kt of contained tin. A major highlight is the 125% increase in the Indicated Resource category, which now stands at 6.05Mt at 0.84% Sn for 50,739 tonnes of contained tin. Consequently, Heemskirk remains the highest-grade undeveloped tin project in Australia and ranks third highest globally among peer projects. Across...

Stockholm, 2nd of July 2026 – Virtune AB (Publ) (“Virtune”) today announces that it has completed the monthly rebalancing of the Virtune Crypto Altcoin Index ETP, listed on Nasdaq Stockholm, Nasdaq Helsinki, Xetra and Warsaw Stock Exchange (ISIN code SE0023260716). In addition to the Virtune Crypto Altcoin Index ETP, Virtune’s product portfolio includes: Virtune Arbitrum ETPVirtune Avalanche ETPVirtune Bitcoin ETPVirtune Bitcoin Prime ETPVirtune Bittensor ETPVirtune BNB ETPVirtune Chainlink ETPVirtune Coinbase 50 Index ETPVirtune Crypto Altcoin Index ETPVirtune Crypto Top 10 Index ETP EURVirtune Crypto Top 10 Index ETP SEKVirtune Hyperliquid ETPVirtune Litecoin ETPVirtune Polygon ETPVirtune Stablecoin Index ETPVirtune Staked Cardano ETPVirtune Staked Ethereum ETPVirtune Staked Near ETPVirtune Staked Polkadot ETPVirtune Staked...

Press Release Information on the total number of voting rights and shares of 74Software share capital as of June 30, 2026 Paris, July 2, 2026 – In accordance with Articles L.233-8 II and R.225-73 I of the French Commercial Code (Code de Commerce) and Article 223-16 of the General Regulations of the Autorité des Marchés Financiers (RGAMF), 74Software hereby informs its shareholders that, as of June 30, 2026:Total number of shares is 29,746,194. Total number of theoretical voting rights is 41,328,280.It is calculated according to the total number of shares with voting rights, including those whose voting rights have been suspended, and is used to declare threshold crossing by shareholders in accordance with Article 223-11 of the RGAMF.Number of exercisable voting rights is 40,664,803.Disclaimer This document is a translation...

ZUG, Switzerland, July 2, 2026 – Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing neuro-ophthalmic and ophthalmic diseases with significant unmet medical needs, announced today that Oculis’ management will participate in a fireside chat at the Piper Sandler Virtual Ophthalmology Conference. The Company will provide an overview and update of its innovative current late-stage portfolio. Key highlights include: Privosegtor, a novel neuroprotective candidate which received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) and Priority Medicines (PRIME) designation from the European Medicines Agency (EMA) for optic neuritis (ON), in the PIONEER registrational program to address unmet needs for two optic neuropathies targeting...

Demonstrations highlight secure, frictionless authentication delivering substantial ROI for financial institutions AMMAN, Jordan and MADRID, July 02, 2026 (GLOBE NEWSWIRE) — BIO-key International, Inc. (OTCQB: BKYI), a global leader in biometric-powered identity and access management (IAM), will participate in an invitation-only cybersecurity and identity workshop hosted in Amman  by the Association of Banks in Jordan on July 6th. The invitation-only government-sponsored event brings together cybersecurity, IT, digital transformation, and management leaders from leading banks and financial institutions across Jordan to address cyber threats, identity security challenges, modern authentication strategies and IT return-on-investment. Over 25 institutions, including C-level executives, have confirmed attendance. Attendees will learn...

PRESS RELEASE                                         Share Buyback Transaction Details June 25 – July 1, 2026 Alphen aan den Rijn – July 2, 2026 – Wolters Kluwer (Euronext: WKL), a global leader in professional information solutions, software and services, today reports that it has repurchased 110,222 of its own ordinary shares in the period from June 25, 2026, up to and including July 1, 2026, for €6.2 million and at an average share price of €56.24. These repurchases are part of the share buyback program announced on February 25, 2026, under which we intend to repurchase shares for up to €500 million during 2026. The cumulative amounts repurchased in the year to date under this program are as follows: Share Buyback 2026Period Cumulative shares repurchased in period Total consideration(€ million) Average share price(€)2026...

ZUG, Switzerland, July 02, 2026 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing neuro-ophthalmic and ophthalmic diseases with significant unmet medical needs, announced today that Oculis’ management will participate in a fireside chat at the Piper Sandler Virtual Ophthalmology Conference. The Company will provide an overview and update of its innovative current late-stage portfolio. Key highlights include: Privosegtor, a novel neuroprotective candidate which received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) and Priority Medicines (PRIME) designation from the European Medicines Agency (EMA) for optic neuritis (ON), in the PIONEER registrational program to address unmet needs for...

Team ZetaDisplay AustriaZetaDisplay AustriaZetaDisplay is strengthening its position in the Austrian market with the rebranding of Peakmedia, acquired in 2023, as ZetaDisplay Austria. The transition marks the next phase of integration into the wider ZetaDisplay organisation and is further strengthened by the appointment of Marcel Schramm as Country Director. Since joining the team in Ebbs in Austria, Peakmedia has continued to deliver innovative digital signage solutions across the DACH region and Easten Europe, supporting customers with strategic consulting, software, hardware integration, content and managed services. The rebrand marks the next step in the integration of the Austrian team into ZetaDisplay, uniting its established local presence with the scale, expertise and international capabilities of one of Europe’s...

Inside My RaceCapgemini and the Tour de France bring fans personalized, AI-powered insights with ‘Inside My Race’Inside My Race 1Capgemini and the Tour de France bring fans personalized, AI-powered insights with ‘Inside My Race’Inside My Race 3Capgemini and the Tour de France bring fans personalized, AI-powered insights with ‘Inside My Race’Inside My Race 4Capgemini and the Tour de France bring fans personalized, AI-powered insights with ‘Inside My Race’Inside My Race 2Capgemini and the Tour de France bring fans personalized, AI-powered insights with ‘Inside My Race’Capgemini Press contact: Sereydana Oum+33 6 61 42 03 59Sereydana.oum@capgemini.com Tour de France Press contact:Julien Rozenblum +33 6 40 16 67 67jrozenblum@aso.fr Capgemini and the Tour de France bring fans personalized, AI-powered...